Covalon Technologies (CVALF) to Release Quarterly Earnings on Friday

Covalon Technologies (OTCMKTS:CVALF - Get Free Report) will likely be issuing its quarterly earnings data before the market opens on Friday, February 21st. Analysts expect the company to announce earnings of ($0.03) per share and revenue of $6.37 million for the quarter.

Covalon Technologies (OTCMKTS:CVALF - Get Free Report) last announced its quarterly earnings results on Tuesday, January 7th. The company reported $0.01 earnings per share for the quarter. Covalon Technologies had a net margin of 8.58% and a return on equity of 12.33%.

Covalon Technologies Stock Performance

Covalon Technologies stock traded up $0.04 during trading on Thursday, reaching $2.25. 33,532 shares of the company's stock were exchanged, compared to its average volume of 23,559. The company's 50-day moving average is $2.23 and its two-hundred day moving average is $2.32. Covalon Technologies has a 52-week low of $0.74 and a 52-week high of $3.08. The firm has a market cap of $61.65 million, a price-to-earnings ratio of 32.15 and a beta of -0.29.

Covalon Technologies Company Profile

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.